Affiliation: Mount Sinai Hospital
- Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based reviewLouise Bordeleau
Department of Medical Oncology, University of Toronto, Toronto, Ontario, Canada
Clin Ther 29:230-41. 2007..Because of the contribution of sex hormones to breast cancer, the use of hormonal agents for the control of hot flashes is problematic in these women. Safer nonhormonal alternatives are recommended for this patient group...
- Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patientsSophie Kim
Department of Pharmacy, Princess Margaret Hospital, Toronto, Canada
J Oncol Pharm Pract 18:311-5. 2012..We present five cases of chemotherapy-induced infiltrative pneumonitis in breast cancer patients involving docetaxel, paclitaxel, gemcitabine and cyclophosphamide...
- Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing dataLouise Bordeleau
Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 1X5
J Clin Oncol 21:1944-51. 2003..To evaluate the effect of a standardized group psychosocial intervention on health-related quality of life (HrQOL) in women with metastatic breast cancer and to explore the effect of missing data in HrQOL analyses...
- Breast cancer in a BRCA2 mutation carrier with a history of prostate cancerSeema Panchal
University of Toronto, Toronto, Ontario, Canada
Nat Rev Clin Oncol 6:604-7. 2009..Aside from notable gynecomastia, he remained asymptomatic. He has a strong family history of breast cancer with multiple sisters affected...
- Diabetes and breast cancer among women with BRCA1 and BRCA2 mutationsLouise Bordeleau
Juravinski Cancer Centre, Hamilton, Ontario, Canada
Cancer 117:1812-8. 2011..Hyperinsulinemia and the metabolic syndrome are both risk factors for breast cancer. It is not clear if diabetes is associated with the risk of breast cancer in women with a BRCA1 or BRCA2 mutation...
- A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumabSophie Kim
Department of Pharmacy, Princess Margaret Hospital, Toronto, ON, Canada
J Oncol Pharm Pract 18:293-5. 2012..Both dexamethasone and the total lymphocyte nadir predisposed this patient to PJP...
- Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trialAngela M Cheung
University Health Network, University of Toronto, Toronto, ON, Canada
Lancet Oncol 13:275-84. 2012..Exemestane can prevent breast cancer in postmenopausal women. Because of potential widespread use, we examined the safety of exemestane on bone health...
- Willingness of breast cancer survivors to participate in a randomized controlled trial of digital mammography with or without MRI as breast cancer surveillance: a feasibility studyDaphne Tsoi
Department of Medical Oncology, Sunnybrook Odette Cancer Centre, The University of Toronto, 2075 Bayview Ave, Toronto, Ontario, Canada
Breast 20:96-8. 2011..58% agreed to consider participating in the proposed RCT; 16% remained neutral. An RCT of MRI surveillance for BC survivors <age 60 is still feasible at centres where annual MRI is not yet routinely recommended...
- Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancerReuben J Broom
Princess Margaret Hospital, Toronto, Canada
Anticancer Res 29:1557-62. 2009..Changes in the receptor profile between primary and metastatic breast cancer tissue have been suggested. The degree of hormone receptor discordance in archival paired pathological samples was evaluated...
- Treating dural metastases mimicking intracranial hypotensionDaniel Grabarz
J Support Oncol 5:423-4. 2007